Home LiteratureArticle Details
PMID: 21533148 Published · epublish English Journal Article Research Support, N.I.H., Extramural

Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion.

PloS one ·Vol. 6 ·No. 4 ·2011-04-14 ·Pages e18848

Sims JD, McCready J, Jay DG

Abstract

Breast cancer is second only to lung cancer in cancer-related deaths in women, and the majority of these deaths are caused by metastases. Obtaining a better understanding of migration and invasion, two early steps in metastasis, is critical for the development of treatments that inhibit breast cancer metastasis. In a functional proteomic screen for proteins required for invasion, extracellular heat shock protein 90 alpha (Hsp90α) was identified and shown to activate matrix metalloproteinase 2 (MMP-2). The mechanism of MMP-2 activation by Hsp90α is unknown. Intracellular Hsp90α commonly functions with a complex of co-chaperones, leading to our hypothesis that Hsp90α functions similarly outside of the cell. In this study, we show that a complex of co-chaperones outside of breast cancer cells assists Hsp90α mediated activation of MMP-2. We demonstrate that the co-chaperones Hsp70, Hop, Hsp40, and p23 are present outside of breast cancer cells and co-immunoprecipitate with Hsp90α in vitro and in breast cancer conditioned media. These co-chaperones also increase the association of Hsp90α and MMP-2 in vitro. This co-chaperone complex enhances Hsp90α-mediated activation of MMP-2 in vitro, while inhibition of Hsp70 in conditioned media reduces this activation and decreases cancer cell migration and invasion. Together, these findings support a model in which MMP-2 activation by an extracellular co-chaperone complex mediated by Hsp90α increases breast cancer cell migration and invasion. Our studies provide insight into a novel pathway for MMP-2 activation and suggest Hsp70 as an additional extracellular target for anti-metastatic drug development.

MeSH Terms
Breast Neoplasms/pathology Cell Line, Tumor Enzyme Activation Female HSP70 Heat-Shock Proteins/physiology HSP90 Heat-Shock Proteins/physiology Humans Matrix Metalloproteinase 2/metabolism Neoplasm Invasiveness Neoplasm Metastasis
Chemicals
HSP70 Heat-Shock Proteins HSP90 Heat-Shock Proteins HSP90AA2P protein, human Matrix Metalloproteinase 2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Sims Jessica D
Department of Cellular and Molecular Physiology, Sackler School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
McCready Jessica
Jay Daniel G
References (53)
53 references, click to expand
  1. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.
    Exp Biol Med (Maywood). 2003 Feb;228(2):111-33 PMID: 12563018
  2. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
    Int J Dev Biol. 2004;48(5-6):411-24 PMID: 15349816
  3. Genes that mediate breast cancer metastasis to lung.
    Nature. 2005 Jul 28;436(7050):518-24 PMID: 16049480
  4. Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase.
    Lab Invest. 2002 Nov;82(11):1583-90 PMID: 12429818
  5. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):364-8 PMID: 2153297
  6. The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis.
    Nat Struct Mol Biol. 2009 Mar;16(3):281-6 PMID: 19234469
  7. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Nature. 2003 Sep 25;425(6956):407-10 PMID: 14508491
  8. Endothelial cell regulation of matrix metalloproteinases.
    Can J Physiol Pharmacol. 2005 Jan;83(1):1-7 PMID: 15759044
  9. HSP90 as a new therapeutic target for cancer therapy: the story unfolds.
    Expert Opin Biol Ther. 2002 Jan;2(1):3-24 PMID: 11772336
  10. Metastasis: from dissemination to organ-specific colonization.
    Nat Rev Cancer. 2009 Apr;9(4):274-84 PMID: 19308067
  11. Hsp90 & Co. - a holding for folding.
    Trends Biochem Sci. 1999 Apr;24(4):136-41 PMID: 10322418
  12. Gaseous nitrogen oxide promotes human lung cancer cell line A549 migration, invasion, and metastasis via iNOS-mediated MMP-2 production.
    Toxicol Sci. 2008 Dec;106(2):364-75 PMID: 18796497
  13. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.
    J Biol Chem. 2000 Feb 4;275(5):3305-12 PMID: 10652318
  14. The regulatory mechanism of Hsp90alpha secretion from endothelial cells and its role in angiogenesis during wound healing.
    Biochem Biophys Res Commun. 2010 Jul 16;398(1):111-7 PMID: 20558142
  15. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance.
    Vet Immunol Immunopathol. 2006 Oct 15;113(3-4):267-76 PMID: 16822550
  16. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing.
    Mol Cell Biol. 2008 May;28(10):3344-58 PMID: 18332123
  17. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.
    Pathol Oncol Res. 2008 Sep;14(3):219-31 PMID: 18575829
  18. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.
    Nat Cell Biol. 2004 Jun;6(6):507-14 PMID: 15146192
  19. The assembly of progesterone receptor-hsp90 complexes using purified proteins.
    J Biol Chem. 1998 Dec 4;273(49):32973-9 PMID: 9830049
  20. Molecular interactions in cancer cell metastasis.
    Acta Histochem. 2010;112(1):3-25 PMID: 19162308
  21. Control of matrix metalloproteinase catalytic activity.
    Matrix Biol. 2007 Oct;26(8):587-96 PMID: 17669641
  22. Cancer statistics, 2009.
    CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 PMID: 19474385
  23. Extracellular heat shock protein 90 induces interleukin-8 in vascular smooth muscle cells.
    Biochem Biophys Res Commun. 2009 Jan 16;378(3):444-9 PMID: 19028451
  24. Heat shock protein 90.
    Curr Opin Oncol. 2003 Nov;15(6):419-24 PMID: 14624223
  25. Gelatinase A activity directly modulates melanoma cell adhesion and spreading.
    EMBO J. 1995 Mar 1;14(5):908-17 PMID: 7534227
  26. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
    Clin Exp Metastasis. 1997 Jan;15(1):26-32 PMID: 9009103
  27. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review.
    Med Sci Monit. 2009 Feb;15(2):RA32-40 PMID: 19182722
  28. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation.
    BMC Cancer. 2010 Jun 16;10:294 PMID: 20553606
  29. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone.
    Cancer Lett. 2004 Apr 8;206(2):149-57 PMID: 15013520
  30. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.
    J Biol Chem. 2008 Jan 25;283(4):2031-41 PMID: 18056992
  31. hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1.
    Biochemistry. 2000 Nov 21;39(46):14314-21 PMID: 11087380
  32. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
    Exp Dermatol. 2004 Jan;13(1):27-32 PMID: 15009113
  33. Activation mechanisms of matrix metalloproteinases.
    Biol Chem. 1997 Mar-Apr;378(3-4):151-60 PMID: 9165065
  34. Extracellular roles for the molecular chaperone, hsp90.
    Cell Cycle. 2004 Sep;3(9):1098-100 PMID: 15326368
  35. Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system.
    J Biol Chem. 2004 Oct 29;279(44):45379-88 PMID: 15302889
  36. Extracellular ATP in the immune system: more than just a "danger signal".
    Sci Signal. 2009 Feb 03;2(56):pe6 PMID: 19193605
  37. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
    J Biol Chem. 1993 Jul 5;268(19):14033-9 PMID: 8314771
  38. Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing.
    EMBO J. 2007 Mar 7;26(5):1221-33 PMID: 17304217
  39. The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes.
    J Biol Chem. 1999 Jun 18;274(25):17525-33 PMID: 10364185
  40. Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis.
    Cancer Sci. 2007 Oct;98(10):1536-9 PMID: 17645779
  41. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion.
    Oncogene. 2008 Apr 10;27(17):2478-87 PMID: 17968312
  42. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance.
    Methods. 2007 Nov;43(3):229-37 PMID: 17920520
  43. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.
    J Leukoc Biol. 2007 Jan;81(1):15-27 PMID: 16931602
  44. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?
    Cell Cycle. 2010 Apr 15;9(8):1542-50 PMID: 20372081
  45. The hallmarks of cancer.
    Cell. 2000 Jan 7;100(1):57-70 PMID: 10647931
  46. The regulatory mechanism of extracellular Hsp90{alpha} on matrix metalloproteinase-2 processing and tumor angiogenesis.
    J Biol Chem. 2010 Dec 17;285(51):40039-49 PMID: 20937816
  47. Matrix metalloproteinase inhibitors.
    Invest New Drugs. 1997;15(1):61-75 PMID: 9195290
  48. Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation.
    J Biol Chem. 2010 May 21;285(21):15714-23 PMID: 20348093
  49. Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression.
    J Biol Chem. 2010 Aug 13;285(33):25458-66 PMID: 20558745
  50. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.
    Biochem J. 2001 Jul 1;357(Pt 1):107-15 PMID: 11415441
  51. Steroid receptor interactions with heat shock protein and immunophilin chaperones.
    Endocr Rev. 1997 Jun;18(3):306-60 PMID: 9183567
  52. Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002.
    Breast. 2007 Aug;16(4):344-51 PMID: 17303426
  53. Matrix metalloproteinase expression in breast cancer.
    J Surg Res. 2003 Apr;110(2):383-92 PMID: 12788669
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2011-04-14
Epub
2011-00-14
Pages
e18848
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3077417
Subset
IM
Grants
NIGMS NIH HHS · K12 GM074869 · United States
NCI NIH HHS · R01 CA116642 · United States
NCI NIH HHS · CA116642 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com